52 
Nestlé buys the rest of Aimmune, aiming to boost a struggling peanut allergy treatment
Bio Pharma Dive
AUGUST 31, 2020
The Swiss firm will take over the launch of Aimmune's Palforzia, sales of which have disappointed since its approval in January
Allergies Related Topics 
Nestlé to acquire Aimmune Therapeutics, growing food allergy portfolio
BioPharma Reporter
SEPTEMBER 1, 2020
Swiss giant Nestlà is to acquire Aimmune Therapeutics, a biopharmaceutical company developing and commercializing treatments for food allergies. Aimmuneâs Palforzia is the worldâs first approved treatment for peanut allergy.
Join
thousands
INSIDERS
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA rejects a peanut allergy treatment, sinking a small biotech's shares
Bio Pharma Dive
AUGUST 4, 2020
Given the long list of requirements in the FDA's rejection letter, DBV Technologies likely has years of work ahead to win approval of Viaskin Peanut
Gene variants help explain connection between skin disorder and food allergy risk
Scienmag
AUGUST 14, 2020
Medicine & Health Dermatology Genetics Immunology/Allergies/Asthma Medicine/Health Pediatrics
Spectrum Veterinary Integrates Revolutionary New Testing Reagent to Its Allergy Testing Technology That Reduces False-Positive Results for Pet Allergies
BioTech 365
SEPTEMBER 1, 2020
leader in companion-animal allergy testing and treatment, has incorporated a new blocking reagent to advance its already fully automated allergy-testing process. The reagent addresses naturally occurring cross-reactive carbohydrate determinants (CCDs) that result in false-positive allergy … Continue reading → Business WirePHOENIX–(BUSINESS WIRE)–#nextmune–Spectrum Veterinary, the U.S.
Latitude Expands Innovative Food Allergy Care to Families Across the Bay Area
BioTech 365
SEPTEMBER 30, 2020
Pioneering a new standard of food allergy care, Latitude takes the next step towards building a national network of its specialized clinics and services REDWOOD CITY, Calif.–(BUSINESS
Allergy Immunotherapies Market – Actionable Research on COVID-19 | Increasing Prevalence of Allergies to Boost the Market Growth | Technavio
BioTech 365
OCTOBER 7, 2020
LONDON–(BUSINESS WIRE)–#AllergyImmunotherapiesMarket–The global allergy immunotherapies market size is poised to grow by USD 626.77 million during 2020-2024, progressing at a CAGR of about 7% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date … Continue reading → Business Wire
Largest European Qualitative Study on Peanut Allergy Highlights Negative Impact of Avoidance and Fear of Accidental Peanut Allergy Reactions on Allergic Individuals and Their Caregivers
BioTech 365
AUGUST 24, 2020
LONDON–(BUSINESS WIRE)–Aimmune Therapeutics, Inc.
Camallergy Chief Medical Officer Receives Distinguished Award from British Allergy Society
BioTech 365
OCTOBER 6, 2020
-BSACI honours Dr Andrew Clark with William Frankland Award for outstanding contributions to clinical allergy CAMBRIDGE, England–(BUSINESS WIRE)–#anaphylaxis–Cambridge Allergy Ltd (“Camallergy” or “the Company”), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced the … Continue reading → Business Wire
DBV craters on FDA’s peanut allergy immunotherapy rejection
Pharma Phorum
AUGUST 5, 2020
DBV Technologies’ long and tortuous path to an FDA verdict on its Viaskin Peanut allergy shot has led to another dead end. million people with peanut allergy in the US, one million of them under the age of 18.
Aimmune’s peanut allergy med moves toward EU approval
Pharma Times
OCTOBER 20, 2020
CHMP grants Palforzia a positive opinion for the treatment of peanut allergic patients
FDA Issues CRL for DBV Technologies' Viaskin Peanut Allergy Patch
BioSpace
AUGUST 3, 2020
In its CRL, the FDA identified concerns regarding the impact of patch-site adhesion on efficacy and indicated the need for patch modifications
IgGenix Launches with $10 Million to Develop Therapeutics for Severe Allergies
BioSpace
AUGUST 3, 2020
emerged from stealth mode with $10 million in Series A financing and a goal to advance the company’s novel antibody therapeutics platform for the treatment of food and non-food allergies, as well as other severe allergic conditions Startup IgGenix, Inc.
Global Ragweed Pollen Allergy Treatment Market to be valued at US$ 1,147.3 Million by 2027, Says Coherent Market Insights (CMI)
BioTech 365
AUGUST 10, 2020
SEATTLE–(BUSINESS WIRE)–#RagweedPollenAllergyTreatment–According to Coherent Market Insights, the global ragweed pollen allergy treatment market is estimated to be valued at US$ 836.9
Allergy Rhinitis Drugs Market – Actionable Research on COVID-19 | Growing Awareness about Allergic Rhinitis to Boost the Market Growth | Technavio
BioTech 365
OCTOBER 7, 2020
LONDON–(BUSINESS WIRE)–#AllergyRhinitisDrugsMarket–The global allergy rhinitis drugs market size is poised to grow by USD 2.4 billion during 2020-2024, progressing at a CAGR of almost 4% throughout the forecast period, according to the latest report by Technavio. The report offers an … Continue reading → Business Wire
Zydus starts Phase II COVID-19 vaccine trial; Taysha raises $95M; FDA declines DBV’s peanut allergy patch; Combating COVID-19 with decoy target
Delveinsight
AUGUST 6, 2020
FDA turns back peanut allergy patch of DBV Technologies. A peanut allergy patch which is based on new delivery technology has hit a snag at the FDA. Zydus starts phase 2 COVID-19 vaccine trial after clearing safety test.
Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19
BioTech 365
OCTOBER 8, 2020
— Final Day 29 Data Show Superior Efficacy of Veklury Compared with Placebo in Hospitalized Patients Receiving Standard of Care — — Overall, Treatment with Veklury Resulted in Five Days Faster Recovery and Reduced Disease Progression Compared with Placebo — … Continue reading → Business Wire
Nestle makes newly acquired Aimmune a stand-alone unit, appoints new CEO
Bio Pharma Dive
OCTOBER 14, 2020
Andrew Oxtoby, formerly chief commercial officer at the peanut allergy drugmaker, will take over as head of the new Nestle business
CBD helps reduce lung damage from COVID by increasing levels of protective peptide
Scienmag
OCTOBER 18, 2020
Biology Cell Biology Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health Pulmonary/Respiratory Medicine Virology
Dr. Reddy’s announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market
BioTech 365
SEPTEMBER 16, 2020
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS –(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr.
EU approves new indication for Novartis’ Xolair
Pharma Times
AUGUST 7, 2020
Allergy drug approved for severe chronic rhinosinusitis with nasal polyps
Could an existing vaccine make COVID-19 less deadly? Mexico City study provides support
Scienmag
OCTOBER 14, 2020
A prospective observational study testing the concept of trained immunity for protection from severe COVID-19 reported milder symptoms in COVID patients receiving MMR vaccination, as published in Allergy.
Attend the 2020 ACAAI Annual Scientific Meeting from where you are sitting right now
Scienmag
SEPTEMBER 18, 2020
This year’s groundbreaking allergy and asthma news will be delivered virtually, and for free. Every year you rely on the American College of Allergy, Asthma and Immunology’s Annual Scientific Meeting to deliver the most recent updates on what is happening in the world of allergy and asthma research and treatment. Medicine & Health Immunology/Allergies/Asthma
New imaging method reveals HIV’s sugary shield in unprecedented detail
Scienmag
OCTOBER 23, 2020
Medicine & Health Cell Biology Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health VirologyThe technique should help in the design of vaccines against HIV, SARS-CoV-2 and other viruses that cloak their outer proteins with sugars to evade antibodies.
Could BCG vaccine protect against COVID-19? UK recruitment begins
Scienmag
OCTOBER 11, 2020
Medicine & Health Grants/Funding Health Professionals Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health Public Health
NIH award to fuse immunology and neuroscience research
Scienmag
OCTOBER 22, 2020
Medicine & Health Endocrinology Immunology/Allergies/Asthma Medicine/Health NeurobiologyCredit: Virginia Tech Gabriela Carrillo didn’t always aspire to be a neuroscientist.
Inhibitor of KRAS gene mutation shows promise in lung, bowel and other solid tumors
Scienmag
OCTOBER 25, 2020
Cancer cancer Clinical Trials Gastroenterology Genes Genetics Immunology/Allergies/Asthma Medicine/Health Pulmonary/Respiratory Medicine Urogenital SystemLatest results from KRYSTAL-1 early clinical trial of adagrasib (MRTX849) Credit: Pasi A.
New study reveals why flu can be devastating for pregnant women
Scienmag
SEPTEMBER 22, 2020
Infectious Emerging Diseases Developmental/Reproductive Biology Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health Virology
Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
Scienmag
OCTOBER 20, 2020
Cancer Bacteriology cancer Cardiology Dentistry/Periodontal Disease Immunology/Allergies/Asthma Medicine/Health Microbiology
Study identifies key enzyme for development of autoimmune diseases
Scienmag
OCTOBER 19, 2020
Chemistry AND Physics Aging Immunology/Allergies/Asthma Medicine/Health Neurobiology Pharmaceutical SciencesAn enzyme associated with energy production in cells also participates in the differentiation of immune cells involved in exacerbated inflammation.
Enzyme biofactories to enhance cord blood transplants
Scienmag
OCTOBER 22, 2020
Medicine & Health Biochemistry Biomedical/Environmental/Chemical Engineering Biotechnology Immunology/Allergies/Asthma Medicine/Health Molecular Biology
Study connects hormones we’re born with to lifetime risk for immunological diseases
Scienmag
SEPTEMBER 15, 2020
Cancer cancer Genetics Immunology/Allergies/Asthma Internal Medicine Medicine/Health Metabolism/Metabolic Diseases Microbiology Sex-Linked Conditions
Protein produced by the nervous system may help treatments for inflammatory diseases
Scienmag
AUGUST 17, 2020
Rutgers researchers discovered a new role the protein may have in helping to treat allergies, asthma, COPD A Rutgers-led team may have found the key to treating inflammatory diseases like asthma, allergies, chronic fibrosis and chronic obstructive pulmonary disease (COPD). Medicine & Health Cell Biology Immunology/Allergies/Asthma Medicine/Health
Immune cell activation in severe COVID-19 resembles lupus
Scienmag
OCTOBER 9, 2020
Medicine & Health Cell Biology Critical Care/Emergency Medicine Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health Pulmonary/Respiratory MedicineExtrafollicular B cell pathway In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease.
Immune activation in the liver illuminated with new glycan-tagging strategy
Scienmag
OCTOBER 19, 2020
Chemistry AND Physics Biochemistry Biology Biomedical/Environmental/Chemical Engineering Biotechnology Cell Biology Immunology/Allergies/Asthma Internal Medicine Liver Molecular Biology
CNIO team finds how melanoma ‘deceives’ the immune system, increasing resistance to immunotherapy
Scienmag
OCTOBER 19, 2020
Technology and Engineering Biology Biomedical/Environmental/Chemical Engineering Biotechnology cancer Dermatology Genes Genetics Immunology/Allergies/Asthma Medicine/Health Molecular BiologyCredit: A.
Natural killer cells also have a memory function
Scienmag
OCTOBER 19, 2020
Biology Immunology/Allergies/Asthma Medicine/Health Molecular Biology
Protein that keeps immune system from freaking out could form basis for new therapeutics
Scienmag
OCTOBER 14, 2020
Chemistry AND Physics Bacteriology Biochemistry Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health Microbiology Molecular Biology
Computer model shows how COVID-19 could lead to runaway inflammation
Scienmag
SEPTEMBER 28, 2020
Biology Critical Care/Emergency Medicine Genetics Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health Molecular Biology Pediatrics Toxicology VirologyCredit: Serkan Eldeleklio?lu lu PITTSBURGH, Sept.
New population of immune cells could play a role in multiple sclerosis
Scienmag
OCTOBER 23, 2020
Biology Immunology/Allergies/AsthmaResearchers uncover defining features of a subset of T-cells that may drive autoimmunity in MS, and could prove to be a new target for therapy. PHILADELPHIA – Multiple sclerosis (MS) is an autoimmune disorder that develops as immune cells attack the nervous system. T cells are a critical part of our immune system, with a […].
Let's personalize your content